title: Natural products to drugs: natural product-derived compounds in clinical trials.
abstract: Natural product and natural product-derived compounds that are being evaluated in clinical trials or are in registration (as at 31st December 2007) have been reviewed, as well as natural product-derived compounds for which clinical trials have been halted or discontinued since 2005. Also discussed are natural product-derived drugs launched since 2005, new natural product templates and late-stage development candidates.
authors.affiliation: MerLion Pharmaceuticals, 1 Science Park Road, The Capricorn 05-01, Singapore Science Park II, Singapore 117528. mark@merlionpharma.com
authors.forename: Mark S
authors.initials: MS
authors.lastname: Butler
mesh_terms: D001688:Biological Products / Q000737:chemistry / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000639:trends*; D015394:Molecular Structure; D004364:Pharmaceutical Preparations / Q000737:chemistry*
chemical_list: D001688:Biological Products; D004364:Pharmaceutical Preparations